ArticleCell death & disease2026

EphB4 inhibition defines a druggable synthetic-lethal vulnerability in MYC-driven triple-negative breast cancer.

Zhe Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.